Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis

Eur Urol. 2025 Aug;88(2):212-214. doi: 10.1016/j.eururo.2025.05.015. Epub 2025 May 26.

Authors

Daniel S Roberson¹, Vidit Sharma¹, Stephen A Boorjian¹, Matthew T McLeay 2nd¹, Giuseppe Reitano¹, Mimi V Nguyen², Jacob J Orme¹, Daniel S Childs¹, Lance C Pagliaro¹, Aaron M Potretzke¹, R Jeffrey Karnes¹, Paras Shah¹, Andrew Zganjar³, Timothy Lyon³, Mark D Tyson², Abhinav Khanna⁴

Affiliations

¹ Mayo Clinic, Rochester, MN, USA.
² Mayo Clinic, Scottsdale, AZ, USA.
³ Mayo Clinic, Jacksonville, FL, USA.
⁴ Mayo Clinic, Rochester, MN, USA. Electronic address: khanna.abhinav@mayo.edu.

PMID: 40425390
DOI: 10.1016/j.eururo.2025.05.015

No abstract available

Publication types

Letter